Correlation Between Avadel Pharmaceuticals and ScanSource

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Avadel Pharmaceuticals and ScanSource at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avadel Pharmaceuticals and ScanSource into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avadel Pharmaceuticals PLC and ScanSource, you can compare the effects of market volatilities on Avadel Pharmaceuticals and ScanSource and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avadel Pharmaceuticals with a short position of ScanSource. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avadel Pharmaceuticals and ScanSource.

Diversification Opportunities for Avadel Pharmaceuticals and ScanSource

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Avadel and ScanSource is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Avadel Pharmaceuticals PLC and ScanSource in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ScanSource and Avadel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avadel Pharmaceuticals PLC are associated (or correlated) with ScanSource. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ScanSource has no effect on the direction of Avadel Pharmaceuticals i.e., Avadel Pharmaceuticals and ScanSource go up and down completely randomly.

Pair Corralation between Avadel Pharmaceuticals and ScanSource

Given the investment horizon of 90 days Avadel Pharmaceuticals PLC is expected to generate 1.76 times more return on investment than ScanSource. However, Avadel Pharmaceuticals is 1.76 times more volatile than ScanSource. It trades about 0.04 of its potential returns per unit of risk. ScanSource is currently generating about 0.05 per unit of risk. If you would invest  692.00  in Avadel Pharmaceuticals PLC on October 11, 2024 and sell it today you would earn a total of  377.00  from holding Avadel Pharmaceuticals PLC or generate 54.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Avadel Pharmaceuticals PLC  vs.  ScanSource

 Performance 
       Timeline  
Avadel Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
ScanSource 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days ScanSource has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, ScanSource is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Avadel Pharmaceuticals and ScanSource Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Avadel Pharmaceuticals and ScanSource

The main advantage of trading using opposite Avadel Pharmaceuticals and ScanSource positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avadel Pharmaceuticals position performs unexpectedly, ScanSource can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ScanSource will offset losses from the drop in ScanSource's long position.
The idea behind Avadel Pharmaceuticals PLC and ScanSource pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency